| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Chief Medical Officer | Common Stock | 198K | $7.42M | $37.37 | Jan 5, 2024 | Direct |
| Athira Pharma, Inc. | CHIEF MEDICAL OFFICER | Stock Option (Right to Buy) | 400K | Apr 15, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | Apr 15, 2024 | 1 | $0 | 4 | Apr 16, 2024 | CHIEF MEDICAL OFFICER |
| ATHA | Athira Pharma, Inc. | Apr 15, 2024 | 0 | $0 | 3 | Apr 16, 2024 | CHIEF MEDICAL OFFICER |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 4, 2024 | 4 | -$293K | 4 | Jan 8, 2024 | Chief Medical Officer |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Nov 20, 2023 | 2 | -$567K | 4 | Nov 22, 2023 | Chief Medical Officer |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 4, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Chief Medical Officer |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Nov 21, 2022 | 2 | -$585K | 4 | Nov 22, 2022 | Chief Medical Officer |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Nov 19, 2021 | 3 | -$1.35M | 4 | Nov 22, 2021 | Chief Medical Officer |